Neuregulin 1 hypomorphic mutant mice: Enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation

International Journal of Neuropsychopharmacology

Volumn 12, Issue 10, 2009, Pages 1383-1393

  Van Den Buuse, Maarten ^a,b   Wischhof, Lena ^a   Xi Lee, Ruo ^a   Martin, Sally ^a   Karl, Tim ^c,d,e  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^d GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

Locomotor hyperactivity; mice; Neuregulin 1; prepulse inhibition; schizophrenia

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; AMPHETAMINE; APOMORPHINE; DIZOCILPINE; DOPAMINE 2 RECEPTOR; NEU DIFFERENTIATION FACTOR; PHENCYCLIDINE; SEROTONIN 1A RECEPTOR;

ARTICLE; CONTROLLED STUDY; FOREBRAIN; GENE MUTATION; GENOTYPE; HIPPOCAMPUS; LOCOMOTION; MOUSE; MOUSE STRAIN; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; RAPHE NUCLEUS; REGULATORY MECHANISM; STARTLE REFLEX; STATISTICAL SIGNIFICANCE; WILD TYPE;

EID: 84855463704     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709000388     Document Type: Article

References (42)

1. Bailey KR, Rustay NR, Crawley JN (2006). Behavioral phenotyping of transgenic and knockout mice: practical concerns and potential pitfalls. Institute for Laboratory Animal Research Journal 47, 124-131.
2. Bjarnadottir M, Misner DL, Haverfield-Gross S, Bruun S, et al. (2007). Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation : differential synaptic function in NRG1+/x knock-outs compared with wild-type mice. Journal of Neuroscience 27, 4519-4529. (Pubitemid 46663586)
3. Boucher A, Arnold JC, Duffy L, Schofield PR, et al. (2007). Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of D9-tetrahydrocannabinol. Psychopharmacology 192, 325-336. (Pubitemid 46705399)
4. Braff DL, Freedman R, Schork NJ, Gottesman II (2007). Deconstructing schizophrenia : an overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Research 33, 21-32. (Pubitemid 46026257)
5. Britton DR, Ksir C, Thatcher-Britton K, Young D, et al. (1984). Brain norepinephrine depleting lesions selectively enhance behavioral responsiveness to novelty. Physiology and Behavior 33, 473-478. (Pubitemid 14010077)
6. Brocco M, Dekeyne A, Veiga S, Girardon S, et al. (2002). Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Pharmacology Biochemistry and Behavior 71, 667-680.
7. Chartoff EH, Heusner CL, Palmiter RD (2005). Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Neuropsychopharmacology 30, 1324-1333. (Pubitemid 40848086)
8. Chen YJ, Johnson MA, LiebermanMD, Goodchild RE, et al. (2008). Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. Journal of Neuroscience 28, 6872-6883.
9. Choy KHC, de Visser Y, Van den Buuse M (2009). The effect of 'two hit' neonatal and young-adult stress on dopaminergic modulation of prepulse inhibition and dopamine receptor density. British Journal of Pharmacology 156, 388-396.
10. Corfas G, Roy K, Buxbaum JD (2004). Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nature Neuroscience 7, 575-580. (Pubitemid 38691892)
11. Csomor PA, Yee BK, Vollenweider FX, Feldon J, et al. (2008). On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behavioral Neuroscience 122, 885-900.
12. Dean B, Karl T, Pavey G, Boer S, et al. (2008). Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant mice. Schizophrenia Research 99, 341-349. (Pubitemid 351249119)
13. Duffy L, Cappas E, Scimone A, Schofield PR, et al. (2008). Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1. Behavioral Neuroscience 122, 748-759.
14. Falls DL (2006). Neuregulins : functions, forms, and signaling strategies. Experimental Cell Research 284, 14-30.
15. Franklin KBJ, Paxinos G (1996). The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic Press.
16. Gerlai R, Pisacane P, Erickson S (2000). Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behavioural Brain Research 109, 219-227. (Pubitemid 30179672)
17. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia : a decade in review. Psychopharmacology 156, 117-154. (Pubitemid 32702206)
18. Geyer MA, Markou A (1995). Animal models of psychiatric disorders. In : Bloom FE, Kupfer DJ (Eds), Psychopharmacology : The Fourth Generation of Progress (pp. 787-798). New York: Raven Press.
19. Geyer MA, McIlwain KL, Paylor R (2002). Mouse genetic models for prepulse inhibition : an early review. Molecular Psychiatry 7, 1039-1053. (Pubitemid 36044262)
20. Gogos A, Bogeski M, Van den Buuse M (2008). Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. Behavioural Pharmacology 19, 548-561.
21. Gogos A, Martin S, Jones ME, van den Buuse M (2006). Oestrogen modulation of the effect of 8-OH-DPAT on prepulse inhibition : effects of aromatase deficiency and castration in mice. Psychopharmacology 188, 100-110. (Pubitemid 44268246)
22. Golub MS, Germann SL, Lloyd KC (2004). Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse. Behavioural Brain Research 153, 159-170. (Pubitemid 38829299)
23. Hahn CG, Wang HY, Cho DS, Talbot K, et al. (2006). Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nature Medicine 12, 824-828. (Pubitemid 44050073)
24. Harrison PJ, Law AJ (2006). Neuregulin 1 and schizophrenia : Genetics, gene expression, and neurobiology. Biological Psychiatry 60, 132-140.
25. Hashimoto R, Straub RE, Shannon Weickert C, Hyde TM, et al. (2004). Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Molecular Psychiatry 9, 299-307. (Pubitemid 38496722)
26. Juhila J, Honkanen A, Sallinen J, Haapalinna A, et al. (2005). a2A-Adrenoceptors regulate D-amphetamineinduced hyperactivity and behavioural sensitization in mice. European Journal of Pharmacology 517, 74-83. (Pubitemid 40910256)
27. Karl T, Duffy L, Scimone A, Harvey RP, et al. (2007). Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain and Behavior 6, 677-687. (Pubitemid 47476190)
28. Law AJ, Lipska BK, Shannon Weickert C, Hyde TM, et al. (2006). Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proceedings of the National Academy of Sciences USA 103, 6747-6752.
29. Mei L, Xiong WC (2008). Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nature Reviews in Neuroscience 9, 437-452. (Pubitemid 351704944)
30. O'Tuathaigh CM, O'Sullivan GJ, Kinsella A, Harvey RP, et al. (2006). Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice. Neuroreport 17, 79-83. (Pubitemid 43005745)
31. O'Tuathaigh CMP, Babovic D, O'Sullivan GJ, Clifford JJ, et al. (2007a). Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience 147, 18-27. (Pubitemid 46873845)
32. O'Tuathaigh CMP, Babovic D, O'meara G, Clifford JJ, et al. (2007b). Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour. Neuroscience and Biobehavioral Reviews 31, 60-78. (Pubitemid 44880074)
33. O'Tuathaigh CMP, O'Connor A-M, O'Sullivan GJ, Lai D, et al. (2008). Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32, 462-466. (Pubitemid 351178964)
34. Rimer M, Barrett DW, Maldonado MA, Vock VM, et al. (2005). Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. Neuroreport 16, 271-275. (Pubitemid 40364589)
35. Roy K, Murtie JC, El-Khodor BF, Edgar N, et al. (2007). Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proceedings of the National Academy of Sciences USA 104, 8131-8136. (Pubitemid 47185887)
36. Savonenko AV, Melnikova T, Laird FM, Stewart K-A, et al. (2008). Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proceedings of the National Academy of Sciences USA 105, 5585-5590. (Pubitemid 351753906)
37. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. American Journal of Human Genetics 71, 877-892. (Pubitemid 135750519)
38. Tosato S, Dazzan P, Collier D (2005). Association between the neuregulin 1 gene and schizophrenia : a systematic review. Schizophrenia Bulletin 31, 613-617. (Pubitemid 41253313)
39. Van den Buuse M, Garner B, Gogos A, Kusljic S (2005a). Importance of animal models in schizophrenia research. Australian and New Zealand Journal of Psychiatry 39, 550-557. (Pubitemid 41602539)
40. Van den Buuse M, Martin S, Brosda J, Leck KJ, et al. (2005b). Enhanced effect of dopaminergic stimulation on prepulse inhibition in mice deficient in the alpha subunit of Gz. Psychopharmacology 183, 358-367. (Pubitemid 41660422)
41. Van den Buuse M, van Driel IR, Samuelson LC, Pijnappel M, et al. (2005c). Reduced effects of amphetamine on prepulse inhibition of startle in gastrin-deficient mice. Neuroscience Letters 373, 237-242. (Pubitemid 41556565)
42. Walss-Bass C, Liu W, Lew DF, Villegas R, et al. (2006). A novel missense mutation in the transmembrane domain of Neuregulin 1 is associated with schizophrenia. Biological Psychiatry 60, 548-553. (Pubitemid 44402371)